Covalis Capital’s Braskem BAK Stock Holding History

Covalis Capital’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,173,852	Closed	-$4.53M	–	58
2024 Q4	$4.53M	Buy	1,173,852 +250,215	+27%	+$1.38M	0.66%	41
2024 Q3	$6.78M	Buy	+923,637	New	+$6.06M	0.95%	30

Other funds holding BAK

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Covalis Capital's BAK Position: Q1 2025 in Review

Covalis Capital sold out of Braskem (BAK) in Q1 2025, closing a stake of 1,173,852 shares — an estimated $4.53M sold.

Covalis Capital first reported a position in BAK in Q3 2024 and held it in 2 quarters. The position peaked at $6.78M in Q3 2024. 58 funds tracked by Wall St. Rank hold BAK as of Q1 2025.

Covalis Capital reported no remaining Braskem position as of Q1 2025 after selling out during the quarter.
Covalis Capital sold 1,173,852 Braskem shares in Q1 2025, an estimated $4.53M.
Covalis Capital first reported a position in Braskem in Q3 2024 and held it in 2 quarters.
Covalis Capital's Braskem position peaked at $6.78M in Q3 2024.
58 funds tracked by Wall St. Rank held Braskem as of Q1 2025.

Based on Covalis Capital's 13F filing for Q1 2025, filed 15 May 2025.